Related references
Note: Only part of the references are listed.Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency
Baoshan Zhang et al.
MABS (2023)
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Barton F. Haynes et al.
NATURE REVIEWS IMMUNOLOGY (2023)
Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys
Amarendra Pegu et al.
CELL REPORTS (2022)
Combination anti-HIV antibodies provide sustained virological suppression
Michael C. Sneller et al.
NATURE (2022)
Prolonged viral suppression with anti-HIV-1 antibody therapy
Christian Gaebler et al.
NATURE (2022)
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial
Boris Julg et al.
NATURE MEDICINE (2022)
Broadly neutralizing antibodies against HIV-1 and concepts for application
Henning Gruell et al.
CURRENT OPINION IN VIROLOGY (2022)
Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1
Colin LaMont et al.
ELIFE (2022)
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
Peter B. Gilbert et al.
NATURE MEDICINE (2022)
A calculated risk: Evaluating HIV resistance to the broadly neutralising antibodies10-1074 and 3BNC117
Panagiota Zacharopoulou et al.
CURRENT OPINION IN HIV AND AIDS (2022)
Engineering pan-HIV-1 neutralization potency through multispecific antibody avidity
Edurne Rujas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials
Yunda Huang et al.
EBIOMEDICINE (2021)
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
L. Corey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Broadly Neutralizing Antibodies for HIV-1 Prevention
Stephen R. Walsh et al.
FRONTIERS IN IMMUNOLOGY (2021)
Broadly neutralizing antibodies for the treatment and prevention of HIV infection
Marina Caskey
CURRENT OPINION IN HIV AND AIDS (2020)
Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention
Kathryn E. Stephenson et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
Christine A. Bricault et al.
CELL HOST & MICROBE (2019)
Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection
Yehuda Z. Cohen et al.
CURRENT OPINION IN HIV AND AIDS (2018)
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections
Kshitij Wagh et al.
PLOS PATHOGENS (2018)
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
Yotam Bar-On et al.
NATURE MEDICINE (2018)
Identification and specificity of broadly neutralizing antibodies against HIV
Laura E. McCoy et al.
IMMUNOLOGICAL REVIEWS (2017)
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
Ling Xu et al.
SCIENCE (2017)
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity
Yaoxing Huang et al.
CELL (2016)
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
Elise Landais et al.
PLOS PATHOGENS (2016)
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C
Kshitij Wagh et al.
PLOS PATHOGENS (2016)
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
Laura E. McCoy et al.
PLOS PATHOGENS (2015)